Dudediligence.

Revvity, Inc

RVTYNYSE · Laboratory Analytical Instruments
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$5,971,149

10 notices · 55,670 sh

Oct 2025 to Oct 2026

Reported ·

$4,680,353

13 sales · 0 buys

Oct 2025 to Jun 2026

The two figures cover different periods.

12 of 13 reported sales carry the 10b5-1 box. Together they are 0.04% of the shares on issue.

PLANNED · FORM 144Oct 2025 to Oct 2026REPORTED · FORM 4Oct 2025 to Jun 2026N2025DJ2026FMAMJJASO2026-10-01: Gonzales Anita, Form 1442026-09-21: Krakowiak Maxwell, Form 1442026-09-16: Vohra Tajinder S, Form 1442026-07-20: Gonzales Anita, Form 1442026-04-20: Gonzales Anita, Form 1442026-02-24: Victor Miriame, Form 1442026-02-23: McMurry-Heath Michelle, Form 1442026-02-05: Singh Prahlad R., Form 1442026-02-05: Goldberg Joel S, Form 1442026-02-02: Vohra Tajinder S, Form 1442026-02-02: Vohra Tajinder S, sold2026-02-05: Goldberg Joel S, sold2026-02-05: Singh Prahlad R., sold2026-02-23: McMurry-Heath Michelle, sold2026-02-24: Victor Miriame, sold2026-04-20: Gonzales Anita, sold
under a no plan named▼ salesize is dollars

Form 144 notices, newest first

2026-10-01Gonzales Anita, Vice President and CAO$13,060
84 shplan 2025-11-07Form 4s on file end Jun 23144 ↗
2026-09-21Krakowiak Maxwell, Please See Remarks$235,728
1,631 shplan 2026-05-19Form 4s on file end Jun 23144 ↗
2026-09-16Vohra Tajinder S, Please See Remarks$1,032,650
7,330 shplan 2026-05-15Form 4s on file end Jun 23144 ↗
2026-07-20Gonzales Anita, Vice President and CAO$9,306
85 shplan 2025-11-07Form 4s on file end Jun 23144 ↗
2026-04-20Gonzales Anita, Vice President and CAO$7,424
80 shplan 2025-11-07144 ↗
Form 4, 2026-04-22: sold 80 at $92.80The sale reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 7, 2025. Form 4 ↗
2026-02-24Victor Miriame, Please See Remarks$180,856
1,862 shplan 2025-11-26144 ↗
Form 4, 2026-02-26: sold 1,862 at $97.13The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 26, 2025. Form 4 ↗
2026-02-23McMurry-Heath Michelle, Director$58,353
600 shno plan date144 ↗
Form 4, 2026-02-25: sold 600 at $97.26The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $97.15 to $97.35. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and... Form 4 ↗
2026-02-05Singh Prahlad R., Please See Remarks$2,557,886
25,525 shplan 2025-02-06144 ↗
Form 4, 2026-02-06: sold 25,525 at $100.21The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 6, 2025. Form 4 ↗
2026-02-05Goldberg Joel S, Please See Remarks$1,274,382
12,717 shplan 2025-02-06144 ↗
Form 4, 2026-02-06: sold 12,717 at $100.21The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 6, 2025. Form 4 ↗
2026-02-02Vohra Tajinder S, Please See Remarks$601,502
5,756 shplan 2025-02-20144 ↗
Form 4, 2026-02-04: sold 5,756 at $104.50The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 20, 2025. Form 4 ↗